D68.3Haemorrhagic disorder due to circulating anticoagulants
Code usage status
Primary diagnosis
May be used as the primary diagnosis
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Complete code in the classification
Use when the diagnosis matches and no exclusion applies.
- Chapter III
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Official Vietnamese name
- Xuất huyết do có kháng đông lưu hành
- Additional WHO coding guidance
- Haemorrhage during long-term use of anticoagulants Hyperheparinaemia Increase in: antithrombin anti-VIIIa anti-IXa anti-Xa anti-XIa Use additional external cause code (Chapter XX), if desired, to identify any administered anticoagulant. Excl.: long-term use of anticoagulants without haemorrhage (Z92.1)
Related D68 codes
D68
Other coagulation defects
D68.0
Primary diagnosis candidate
Von Willebrand disease
D68.1
Primary diagnosis candidate
Hereditary factor XI deficiency
D68.2
Primary diagnosis candidate
Hereditary deficiency of other clotting factors
D68.4
Primary diagnosis candidate
Acquired coagulation factor deficiency
D68.5
Primary diagnosis candidate
Primary thrombophilia
D68.6
Primary diagnosis candidate
Other thrombophilia
D68.8
Primary diagnosis candidate
Other specified coagulation defects
D68.9
Primary diagnosis candidate
Coagulation defect, unspecified
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
